Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
337 Leser
Artikel bewerten:
(1)

Elekta's ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs network

ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with Elekta's (EKTA-B.ST) ProKnow, a web browser-based cloud solution that centralizes radiotherapy data in a secure scalable platform accessible to all 41 of the VA's radiation oncology facilities nationwide.

"ProKnow is designed to give caregivers the ability to evaluate massive amounts of treatment and health data inputted into the platform's cloud server from entire populations of patients - and to share these data among their colleagues at multiple facilities," according to Larry Biscotti, Executive Vice President, North and Central America. "This should help provide the insight to standardize care with the aim of improving treatment management."

The analysis of ProKnow data leveraging the solution's available tools will help drive out variation and facilitate best practices through the standardization of care, Biscotti adds.

"ProKnow will enable remote, collaborative, 24-7 access to data, turning a healthcare network's collective data streams into a consolidated cloud-based 'knowledge center' that the organization can mine for insights," he said.

VA hospitals and community health centers deliver radiotherapy to over 45,000 patients each year.

The VA is not alone in the magnitude of radiotherapy data that are accumulated on a daily basis. Radiotherapy clinics around the world generate terabytes of patient information every day. Like the VA, the insight contained within these data remains locked away without a simple, intuitive analytics solution.

"By providing a centralized and secure cloud-based solution, ProKnow can unlock the data and make it accessible, enabling any radiotherapy provider to connect to clinical teams anywhere, any time," Biscotti says. "We are particularly pleased that the VA has confidence in ProKnow, as Elekta is a proud employer of veterans and active duty military personnel, with many of our engineering and technical positions held by veterans in the US."

Notably, last year, ProKnow helped many radiation therapy departments accommodate Covid-19 restrictions - and keep their patients' treatments on track - by enabling remote plan review and contouring.

For further information, please contact:
Mattias Thorsson
Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012
e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time

Raven Canzeri
Global Director, Media Relations, Elekta
Tel: +1 770-670-2524
e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-s-proknow-to-help-standardize-radiotherapy-for-veterans,c3283608

The following files are available for download:

https://mb.cision.com/Main/35/3283608/1370612.pdf

Release

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.